Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Puerto Rico Healthcare Daily.
Press releases published on June 18, 2025

PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares
TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing is pleased to announce an offering …

Kane Biotech Provides Further Corporate Update
WINNIPEG, Manitoba, June 18, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) provides updates on its reorganizational phase. The Company has terminated its exclusive distribution agreement with ProgenaCare …

Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split
FLORHAM PARK, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced a one-for- …

Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal
SAN MATEO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced that the Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the “Dissolution Proposal”), …

Galapagos presenteerde nieuwe gegevens op ICML 2025 van Cohort 3 van de ATALANTA-1 studie bij patiënten met recidief/refractair indolent NHL, en toonde hoge complete respons- en MRD-negativiteitspercentages aan met de CAR-T-kandidaat GLPG51
Van de 34 patiënten die werden ingeschreven in Cohort 3 van de ATALANTA-1 fase 1/2-studie, ontvingen er 32 GLPG5101; 94% kreeg verse CAR T-cellen toegediend, en 93% werd behandeld binnen zeven dagen na productie GLPG5101 toonde veelbelovende werkzaamheid …

OnlineSemaglutide.org Launches Platform Offering Easy Access to GLP-1 Medications
San Diego, CA, June 18, 2025 (GLOBE NEWSWIRE) -- OnlineSemaglutide.org, a leader in the field of Health …

Spine Surgeon Dr. Michael Gallizzi of The Steadman Clinic Achieves Milestone in Robotic and Endoscopic Surgery
VAIL, Colo., June 18, 2025 (GLOBE NEWSWIRE) -- The Steadman Clinic and Dr. Michael Gallizzi continue to strengthen their reputation as global leaders in advanced surgical technology. Since joining the clinic three years ago, Dr. Gallizzi has performed over …

EarlyHealth Group übernimmt Corena, um ein Wachstum von 100 Millionen US-Dollar im türkischen Life-Sciences-Sektor zu erzielen
ANKARA, Türkei, June 18, 2025 (GLOBE NEWSWIRE) -- EarlyHealth Group, ein globaler Pharmadienstleister, gab heute die Übernahme von Corena Ecza Deposu, dem führenden Pharmadistributor in der Türkei, bekannt und stärkt damit seine Position als einer der größ …

Global Artificial Pancreas Devices Market is Gearing Up for Outstanding Expansion at a CAGR of ~16% by 2032 | DelveInsight
New York, USA, June 18, 2025 (GLOBE NEWSWIRE) -- Global Artificial Pancreas Devices Market is Gearing Up for Outstanding Expansion at a CAGR of ~16% by 2032 | DelveInsight The global surge in diabetes cases is a key factor propelling the artificial …

Life Backup Plan App by Galacxia, Inc. Recognized for Great Potential in Pepperdine’s Most Fundable Companies Competition
Aliso Viejo, CA , June 18, 2025 (GLOBE NEWSWIRE) -- Galacxia, Inc., developer of the Life Backup Plan digital health platform, proudly announces its advancement to the second round of Pepperdine University’s Most Fundable Companies® 2025 competition. The …

WellSpan commits $3.5 million to address housing challenges across central Pennsylvania
York, Pa., June 18, 2025 (GLOBE NEWSWIRE) -- Marking its largest community grant investment in housing initiatives to date, WellSpan is inspiring health through a $3.5 million grant commitment over the next three years to support 12 mission-driven, …

Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
Company announcement – No. 15 / 2025 Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide Body weight reductions of a mean of 11.6% after 28 weeks with dapiglutide escalated up to …

Human Appeal announces summertime UK Comedy Tour
MANCHESTER, United Kingdom, June 18, 2025 (GLOBE NEWSWIRE) -- Following the roaring success of its annual winter Comedy Tour over the last decade, one of the UK’s leading humanitarian aid charities, Human Appeal, today announces its first ever summertime …

Eolo Pharma Publishes First-in-Human Study in Nature Metabolism on Novel Obesity Drug Activating Energy-Burning Pathway
- New data show clinical safety and early efficacy of SANA, a first-in-class compound that targets creatine-dependent thermogenesis MONTEVIDEO, Uruguay, June 18, 2025 (GLOBE NEWSWIRE) -- Eolo Pharma, a clinical-stage biotechnology company developing …

Major Milestone for Marvin’s Home; Pioneering Philadelphia Area Non-profit Completes Its 100th Move-in for Young Adults Aging out of Foster Care Into Independent Living
LANSDALE, Pa., June 18, 2025 (GLOBE NEWSWIRE) -- Mel McDaniel, who six years ago founded the Marvin’s Home non-profit, knows from experience over that time how challenging – even traumatic – it can be for individuals aging out of the foster care system …

One-third of Americans Worry About Climate Change Weekly
Washington, D.C., June 18, 2025 (GLOBE NEWSWIRE) -- New data from the American Psychiatric Association (APA) reveal more than half of adults (55%) believe climate change is impacting Americans’ mental health. More than 40% of adults report personally …

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates
MELVILLE, N.Y., June 18, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is pleased to …

Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025
Presentation underscores unique potential for atrioventricular interval modulation (“AVIM”) therapy to manage blood pressure in older, high-risk patients who have indicators of diastolic dysfunction and progression to heart failure with preserved ejection …

American Kidney Fund Launches Kidney Cancer Education Campaign
ROCKVILLE, Md., June 18, 2025 (GLOBE NEWSWIRE) -- Ahead of World Kidney Cancer Day on June 19, the American Kidney Fund (AKF) today announced a new educational campaign on renal (kidney) cancer. With support from Merck, this campaign will provide people …

Outlook Therapeutics to Participate in a Virtual Investor Lunch Break Event
ISELIN, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it will participate …